TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Updated American College of Cardiology and American Heart Association guidelines issued in March 2026 give coronary artery calcium scans a more central role for some adults whose need for preventive treatment is uncertain. The source report says the scan costs about $100, while arguing that payment and access barriers may keep it out of reach for patients who could benefit.
The American College of Cardiology and American Heart Association gave coronary artery calcium scans a more central role in their March 2026 heart disease prevention guidelines, recommending the test for some adults whose risk is borderline or intermediate and whose decision about preventive treatment remains uncertain. The change addresses a gap between a relatively low-cost scan that can detect calcified artery plaque and a healthcare system that, according to the physicians reporting on the issue, often leaves patients to pay out of pocket.
A coronary artery calcium, or CAC, scan is a brief imaging test that detects and measures calcified plaque in coronary arteries. Cardiologists Arthur Agatston and Oren Mechanic, writing in MedPage Today on October 25, said the scan takes about 10 minutes, costs roughly $100, and uses a fraction of the radiation of a standard chest CT. Those are estimates presented by the authors, not a guarantee of the price or radiation dose at every facility.
The March guideline recommendation applies to adults with borderline or intermediate estimated coronary risk when it is still unclear whether to begin preventive treatment, such as statin medication. The scan can contribute to that decision: the authors say a score of zero may support classifying a person’s risk downward, while a score above 100 can identify people who may benefit from medication and intensive lifestyle measures. A scan result is not, by itself, a treatment decision.
The authors illustrate the potential role with a 52-year-old patient, identified by a changed name, whose standard risk estimate was low but whose CAC score was 220. They say the finding showed substantial plaque for his age and informed a recommendation for drug treatment. The example is an individual case described by the authors, not evidence that every patient with a similar score will have the same outcome.
The Cost of Finding Plaque Earlier
The policy shift matters because it offers clinicians another way to assess risk when standard factors do not settle a prevention decision. Conventional risk calculators use information such as age, cholesterol, blood pressure, diabetes and smoking to estimate the chance of a future event. A CAC scan instead looks for calcified plaque already present. The two approaches provide different information and are not interchangeable for every patient.
The authors frame the issue as a mismatch between prevention costs and emergency care, saying a scan costs about $100 while a heart attack can lead to roughly $50,000 in Medicare spending. These figures are part of their argument for changing payment incentives; the article does not establish a universal Medicare cost for a heart attack or show that routine scans would save money overall. The guideline recommendation is limited to selected patients, and the source does not report a new Medicare coverage policy.
Access is a practical concern. If insurers do not cover a scan in a given case, patients may have to pay themselves, potentially limiting use to those able to afford it. The authors also point to artificial intelligence tools that can look for calcium on chest CT images taken for other reasons. Such analysis could identify people for follow-up, they argue, but widespread use would depend on appropriate validation, clinical processes and access.
Products Worth Considering
OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG
OMRON VIVA 360+ Body Composition Monitor and Smart Scale
Bowflex PR1000 Home Gym
As an affiliate, we earn on qualifying purchases.
From Risk Estimates to Imaging
For decades, prevention decisions have commonly relied on calculators that estimate risk from population-level factors. The authors argue that those tools can miss differences between people: someone with modest cholesterol may still have substantial plaque, while a person with higher cholesterol may have none. A CAC scan adds an imaging measure, but it does not replace a clinician’s assessment or address every kind of coronary disease.
According to Agatston and Mechanic, CAC evidence accumulated over more than three decades, while national guidelines previously gave the test a more limited place. They attribute the slow uptake partly to clinical decision systems designed around standard risk factors, cautious guideline processes, and insurance coverage constraints. The March 2026 guidance represents a change in how the test is positioned, rather than a blanket recommendation to screen all adults.
“The guidelines have finally caught up to the evidence supporting coronary artery calcium scans.”
— Arthur Agatston, MD, and Oren Mechanic, MD, MPH, in MedPage Today
Coverage and Outcomes Still Open
The source report does not specify which Medicare plans or insurers cover CAC scans, what eligibility rules or patient costs apply, or whether the March guideline change has altered reimbursement. Its $100 scan estimate and $50,000 heart attack figure are presented as a general comparison, without a detailed pricing method, population or time period.
The article also does not provide trial results showing that broader scanning reduces heart attacks or total healthcare spending. It argues that the test can improve risk assessment, but the effect of expanding access depends on who is scanned, how results guide care, and whether patients can obtain and follow recommended treatment. The performance and clinical impact of AI-based plaque analysis are also not quantified in the report.
How Guidance Reaches Patients
The next steps will depend on how clinicians, health systems and payers put the updated recommendations into practice. Patients considering a scan can discuss with a qualified healthcare professional whether their risk profile and treatment decision fit the guideline’s intended use, and ask about the scan’s cost and coverage before scheduling it.
Further evidence and clearer coverage information would help establish whether CAC scanning becomes more accessible and whether AI analysis of existing chest CT images can support consistent follow-up. The source report does not name a specific Medicare policy decision or implementation deadline.
Key Questions
What is a coronary artery calcium scan?
A CAC scan is an imaging test that detects and measures calcified plaque in the arteries that supply the heart. It gives clinicians information about plaque burden that is different from a risk estimate based on factors such as cholesterol and blood pressure.
Who do the 2026 guidelines recommend consider a CAC scan?
The report says the ACC/AHA guidelines recommend considering the test for adults with borderline or intermediate coronary risk when the decision about preventive treatment remains uncertain. It is not described as a routine scan for everyone.
Does Medicare pay for a CAC scan?
The source report does not establish whether Medicare covers the scan for a particular patient or plan. Coverage and out-of-pocket costs may depend on the circumstances, so patients should check with their insurer and clinician.
Does a CAC score determine whether someone should take a statin?
No. The scan can inform a prevention discussion, but a score is not a treatment decision on its own. A healthcare professional can interpret the result alongside the patient’s overall risk, health history and preferences.
Source: rss
